
Glycology, Inc., a wholly owned
subsidiary of Adoodle, Inc., is an innovative lifesciences
company committed to bringing to market the strongest possible proven
technologies developed by ourselves and others. The company is
focused on improving health and well-being, through improvements
in immunology, intercellular communication, and nutritional
efficacy. Glycology, Inc. is committed to furthering research in
the amazing field of glyconutrients, and commercializing those
innovations.
Corporate offices are located in
Philadelphia. The product is distributed directly over the
internet, as well as through a series of authorized distributors
and dealers, health food, and retail outlets.
Celsync, an all-natural nutrient has a
revolutionary two-fold approach for maximum effectiveness. First,
Celsync is formulated to combine important well known supplements that
work directly to slow the aging process and improve performance.
Second, Celsync contains a complement of saccharides that surrounds and
coats each cell in your system with all essential glyconutrients. These
nutrients are key to the proper function of our immune systems, which
keep our bodies looking and acting more youthful and strong.
|
LATEST NEWS
Sweet success for new stem cell ID trick
20 Nov 2008
Biomaterial scientists in Manchester believe they have found a new way
of isolating the ‘ingredients’ needed for potential stem cell
treatments for nerve damage and heart disease.
And the technique could also be used in the future to improve the efficiency of bone marrow transplants.
Dr Catherine Merry and Dr Rebecca Baldwin from The School of Materials
– working with colleagues from the Paterson Institute for Cancer
Research and Nijmegen University in the Netherlands – have developed
antibodies that can recognise different patterns within the natural
sugars that coat cells in the body.
Writing in the journal Stem Cells, the Manchester scientists report how
the technique allows cells to be clearly identified depending on
whether the antibodies bind themselves to the cells or not.
Using this method, they can efficiently isolate blood stem cells
generated from embryonic stem cells, which then have the potential to
be used in the treatment of people with heart and blood cell problems.
The researchers report how the sugars displayed on the surface of a
small population of blood stem cells allow them to be distinguished
from similar cells which lack blood forming ability.
They believe these sugars may also allow these cells to respond better
to the signals which instruct them to become mature blood cell types.
Dr Baldwin, who conducted the research, said: “We were surprised to
find that populations of cells which we had previously thought to be
all the same were actually mixtures of cell types with differences in
their cell surface sugars.
“By using the sugar tags to pull apart this jumble of cells, we can
potentially improve the efficiency with which we can make blood cells
from embryonic stem cells. Usually we would need to genetically
manipulate the DNA in the cells to allow us to tag them in this way.
“We believe our research suggests how sugars can be used to help
embryonic stem cells grow in the lab – and also how they can be
instructed to become cell types which could be of use in human
therapies. These sugars are on the surface of almost all cells and we
are looking to see if the same ‘trick’ can be used to make nerve cells.
All cells that make up the tissues of the body – such as skin, liver,
brain and blood – are surrounded by a layer of sugars that coat the
cells. These sugars help the cells to know what type of cell they are
and to respond to the other cells which surround them and the chemical
messages that pass between them.
BUY 1 GET 3 CLEARANCE SALE NOW !!!!
Adoodle, Inc. is a public
company, traded OTC with the symbol ADDE
|

© 2008 Glycology, Inc.
All rights reserved
|
|
|